Prosight Management, LP
- SEC CIK
- 0001617201
- 最新申報
- 2026/8/14
2021 年第 1 季持倉
持倉截至 2021/3/31，2021/5/14 申報。只含多頭部位。
- 持股檔數
- 37
- 2020 年第 4 季沒有 13F 資料
- 總值
- $1.22 億
- 2020 年第 4 季沒有 13F 資料
Livermore 的 13F 資料從 2021 年第 1 季開始，這一季沒有前一季可以比較，所以不顯示股數變化與動作。
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| PRTAProthena Corp Public Ltd Co | SHS | 600,000 | $1,507 萬 | 12.3% | – | – | 歷史 |
| VRTXVertex Pharmaceuticals Inc | Stock | 38,350 | $824.1 萬 | 6.7% | – | – | 歷史 |
| EHCEncompass Health Corp | COM | 100,000 | $819.0 萬 | 6.7% | – | – | 歷史 |
| ARNAArena Pharmaceuticals Inc | COM NEW | 105,828 | $734.3 萬 | 6.0% | – | – | 歷史 |
| CUECue Biopharma, Inc. | COM | 556,777 | $679.3 萬 | 5.6% | – | – | 歷史 |
| BMYBristol Myers Squibb Co | Stock | 95,600 | $603.5 萬 | 4.9% | – | – | 歷史 |
| ALBOAlbireo Pharma, Inc. | COM | 170,352 | $600.5 萬 | 4.9% | – | – | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 473,446 | $562.5 萬 | 4.6% | – | – | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 66,419 | $512.0 萬 | 4.2% | – | – | 歷史 |
| AUPHAurinia Pharmaceuticals Inc. | COM | 360,834 | $468.5 萬 | 3.8% | – | – | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 750,310 | $447.2 萬 | 3.7% | – | – | 歷史 |
| MGTXMeiraGTx Holdings plc | COM | 291,944 | $421.3 萬 | 3.4% | – | – | 歷史 |
| ZGNXZogenix, Inc. | COM NEW | 195,000 | $380.6 萬 | 3.1% | – | – | 歷史 |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 21,197 | $339.3 萬 | 2.8% | – | – | 歷史 |
| PRQRProQR Therapeutics N.V. | SHS EURO | 450,165 | $297.6 萬 | 2.4% | – | – | 歷史 |
| OSCROscar Health, Inc. | CL A | 107,086 | $287.8 萬 | 2.4% | – | – | 歷史 |
| CLLSCellectis S.A. | SPON ADS | 137,900 | $278.7 萬 | 2.3% | – | – | 歷史 |
| INOVInovalon Holdings, Inc. | COM CL A | 85,000 | $244.6 萬 | 2.0% | – | – | 歷史 |
| MDTMedtronic plc | Stock | 20,088 | $237.3 萬 | 1.9% | – | – | 歷史 |
| UNHUnitedHealth Group Inc | Stock | 6,000 | $223.2 萬 | 1.8% | – | – | 歷史 |
| TVRDTvardi Therapeutics, Inc. | COM | 100,000 | $217.1 萬 | 1.8% | – | – | 歷史 |
| MTCRMetacrine, Inc. | COM | 304,485 | $188.8 萬 | 1.5% | – | – | 歷史 |
| SLDBSolid Biosciences Inc. | COM | 320,100 | $177.0 萬 | 1.4% | – | – | 歷史 |
| LHCGLHC Group, Inc | COM | 8,783 | $167.9 萬 | 1.4% | – | – | 歷史 |
| AKUAkumin Inc. | COM | 429,061 | $158.8 萬 | 1.3% | – | – | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 17,000 | $136.1 萬 | 1.1% | – | – | 歷史 |
| ALXNAlexion Pharmaceuticals, Inc. | COM | 8,685 | $132.8 萬 | 1.1% | – | – | 歷史 |
| ONCROncorus, Inc. | COM | 70,807 | $98.6 萬 | 0.8% | – | – | 歷史 |
| APTOAptose Biosciences Inc. | COM NEW | 150,000 | $89.6 萬 | 0.7% | – | – | 歷史 |
| ADMAAdma Biologics, Inc. | COM | 497,842 | $87.6 萬 | 0.7% | – | – | 歷史 |
| XCURExicure, Inc. | COM | 275,848 | $60.1 萬 | 0.5% | – | – | 歷史 |
| SIOXSio Gene Therapies Inc. | COMMON | 205,900 | $53.7 萬 | 0.4% | – | – | 歷史 |
| BAXBaxter International Inc | Stock | 5,800 | $48.9 萬 | 0.4% | – | – | 歷史 |
| ODTOdonate Therapeutics, Inc. | COM | 117,621 | $40.2 萬 | 0.3% | – | – | 歷史 |
| MORFMorphic Holding, Inc. | COM | 5,202 | $32.9 萬 | 0.3% | – | – | 歷史 |
| ORGOOrganogenesis Holdings Inc. | COM | 15,232 | $27.8 萬 | 0.2% | – | – | 歷史 |
| ASMBAssembly Biosciences, Inc. | COM | 56,500 | $26.0 萬 | 0.2% | – | – | 歷史 |